GO:0000244 spliceosomal tri-snRNP complex assembly: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000244 describes the assembly of the U4/U6.U5 tri-snRNP (or U4atac/U6atac.U5 minor tri-snRNP), a pre-assembled module that is essential for spliceosome activation [1, 4, 8].
• The process includes reannealing of U4 and U6 snRNAs after each round of splicing and subsequent association with U5 snRNP to form a recycling-competent tri-snRNP [4, 6].
• Key proteins include PRPF4, PRPF6, PRPF8, PRPF31, and the PRP4 kinase, which phosphorylates PRPF6 to stabilize tri-snRNP association during B complex formation.
• The nuclear cap-binding complex (CBC) interacts with the tri-snRNP and promotes spliceosome assembly in mammalian cells.
• Dysregulation of tri-snRNP assembly is linked to retinitis pigmentosa (RP) through mutations in U4/U6 snRNAs and protein factors.
• Studying GO:0000244 requires structural, biochemical, and genetic approaches, including cryo-EM, RNA-seq, and CRISPR-based knockout/knock-in models [1, 3, 8].
Description
The spliceosomal tri-snRNP complex assembly (GO:0000244) is a critical step in pre-mRNA splicing, where the U4/U6.U5 tri-snRNP is formed and recycled for subsequent rounds of splicing [4, 6]. This process ensures that the spliceosome can efficiently recognize and excise introns, a fundamental mechanism for gene expression in eukaryotes [1, 8]. The tri-snRNP consists of U4 and U6 snRNAs (or their minor variants U4atac and U6atac) base-paired together, plus the U5 snRNP and associated proteins. Assembly of this complex is dynamic and tightly regulated, involving reannealing of U4 and U6 snRNAs after each splicing cycle and the subsequent addition of U5 snRNP. Structural studies have revealed that the tri-snRNP undergoes conformational changes upon integration into the spliceosome, facilitating the cross-exon to cross-intron switch. In human cells, the nuclear cap-binding complex (CBC) interacts with the tri-snRNP and promotes spliceosome assembly, highlighting additional layers of regulation. Given its central role in splicing, defects in tri-snRNP assembly are associated with human diseases, including retinitis pigmentosa. This article provides a comprehensive overview of GO:0000244, covering its definition, mechanism, key genes, disease relevance, and research methodologies, with a focus on CRISPR-based models for functional studies.
spliceosomal tri-snRNP complex assembly At A Glance
| GO ID | GO:0000244 |
|---|---|
| GO term | spliceosomal tri-snRNP complex assembly |
| Ontology | biological_process |
| Synonym | assembly of spliceosomal tri-snRNP; snRNP recycling; spliceosomal tri-snRNP U4/U6.U5 assembly; spliceosomal tri-snRNP U4atac/U6atac.U5 assembly |
| Major function | Formation and recycling of the U4/U6.U5 tri-snRNP for spliceosome assembly |
| Key components | U4, U6, U5 snRNAs; PRPF4, PRPF6, PRPF8, PRPF31, PRP4 kinase, CBC |
| Related pathways | Pre-mRNA splicing, spliceosome cycle |
| Disease relevance | Retinitis pigmentosa, cancer, neurodegeneration |
What Is GO:0000244?
GO:0000244, spliceosomal tri-snRNP complex assembly, is the biological process by which a tri-snRNP complex containing U4 and U6 (or U4atac and U6atac) snRNAs and U5 snRNA, along with associated proteins, is formed. This includes the reannealing of U4 and U6 snRNAs released from previous splicing rounds to reform the U4/U6 snRNP (or U4atac/U6atac snRNP), followed by the association of the U5 snRNP to generate a tri-snRNP that is ready to reassemble into another spliceosome complex [4, 6].
Why Is spliceosomal tri-snRNP complex assembly Important in Cell Biology?
Understanding GO:0000244 is essential because the tri-snRNP is a central building block of the spliceosome, and its assembly is rate-limiting for splicing [4, 6]. Defects in tri-snRNP components or assembly factors lead to splicing defects that can cause human diseases, such as retinitis pigmentosa. Moreover, the tri-snRNP is a target for regulatory mechanisms, including phosphorylation by PRP4 kinase and interaction with the CBC, making it a hub for cellular signaling. Research into this process informs therapeutic strategies for splicing-related disorders and provides insights into fundamental gene expression mechanisms.
• Tri-snRNP assembly is required for the formation of the catalytically active spliceosome [1, 8].
• It ensures recycling of U4/U6 snRNPs after each splicing cycle, maintaining splicing efficiency.
• Mutations in tri-snRNP components cause retinitis pigmentosa, a leading cause of blindness.
• PRP4 kinase-mediated phosphorylation of PRPF6 regulates stable tri-snRNP association.
• The nuclear cap-binding complex promotes tri-snRNP function and spliceosome assembly.
• Tri-snRNP assembly is a potential target for anticancer therapies due to splicing dysregulation in cancer.
• Structural studies of the tri-snRNP provide a framework for understanding spliceosome dynamics [1, 8].
• Minor tri-snRNP (U4atac/U6atac.U5) assembly is essential for U12-type intron splicing.
What Happens During spliceosomal tri-snRNP complex assembly?
Reannealing of U4 and U6 snRNAs
In simple terms: After splicing, U4 and U6 snRNAs need to pair up again to reform the U4/U6 snRNP.
Following each round of splicing, the U4 and U6 snRNAs, which are released from the spliceosome, must reanneal to reform the U4/U6 snRNP. This step is facilitated by proteins such as PRPF4 and PRPF6, which stabilize the RNA duplex [4, 6]. The reannealing is a prerequisite for the subsequent association with U5 snRNP to form the tri-snRNP.
Association of U5 snRNP
In simple terms: The U5 snRNP joins the U4/U6 snRNP to complete the tri-snRNP.
Once the U4/U6 snRNP is reformed, the U5 snRNP associates with it to form the tri-snRNP. This association is mediated by protein-protein interactions, including those involving PRPF8 and PRPF31 [4, 6]. The resulting tri-snRNP is a stable complex that can be recruited to the spliceosome.
Phosphorylation by PRP4 kinase
In simple terms: A kinase called PRP4 adds phosphate groups to a tri-snRNP protein to help it stay together.
Human PRP4 kinase phosphorylates PRPF6, a component of the tri-snRNP, which is required for stable tri-snRNP association during spliceosomal B complex formation. This phosphorylation event is a key regulatory step in tri-snRNP assembly and function.
Interaction with nuclear cap-binding complex
In simple terms: A protein complex that binds the cap of mRNA interacts with the tri-snRNP to help splicing.
The nuclear cap-binding complex (CBC) interacts with the U4/U6.U5 tri-snRNP and promotes spliceosome assembly in mammalian cells. This interaction links tri-snRNP function to mRNA processing and may coordinate splicing with other steps of gene expression.
Structural rearrangements and spliceosome integration
In simple terms: The tri-snRNP changes shape when it joins the spliceosome to enable splicing.
Structural studies have revealed that the tri-snRNP undergoes significant conformational changes upon integration into the spliceosome, including the cross-exon to cross-intron switch. Cryo-EM structures of the pre-catalytic spliceosome show the tri-snRNP in a poised state, ready for activation. These rearrangements are essential for catalytic activation and intron recognition [1, 8].
Key Genes Involved in GO:0000244 spliceosomal tri-snRNP complex assembly
The following genes and proteins are core components or regulators of spliceosomal tri-snRNP complex assembly (GO:0000244).
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRPF4 | U4/U6 snRNP protein, stabilizes U4/U6 duplex | Mutations linked to retinitis pigmentosa; target for splicing studies [4, 5] |
| PRPF6 | Tri-snRNP component, phosphorylated by PRP4 kinase | Regulates stable tri-snRNP association; cancer and RP research |
| PRPF8 | U5 snRNP protein, core spliceosome component | Essential for tri-snRNP assembly and catalysis; mutations in RP [4, 8] |
| PRPF31 | U4/U6.U5 tri-snRNP protein | Mutations cause retinitis pigmentosa; splicing factor |
| PRP4 (PRPF4B) | Kinase that phosphorylates PRPF6 | Regulates tri-snRNP stability; potential drug target |
| U4 snRNA | Non-coding RNA component of tri-snRNP | Mutations cause retinitis pigmentosa |
| U6 snRNA | Non-coding RNA component of tri-snRNP | Mutations cause retinitis pigmentosa |
| U5 snRNA | Non-coding RNA component of tri-snRNP | Essential for splicing; structural studies [1, 8] |
| U4atac snRNA | Minor tri-snRNP RNA | Mutations cause microcephalic osteodysplastic primordial dwarfism type I |
| U6atac snRNA | Minor tri-snRNP RNA | Essential for U12-type intron splicing |
| CBC (NCBP1/NCBP2) | Cap-binding complex, interacts with tri-snRNP | Promotes spliceosome assembly |
| PRPF3 | U4/U6 snRNP protein | Mutations in retinitis pigmentosa; tri-snRNP stability |
| PRPF5 | U4/U6 snRNP protein | Component of tri-snRNP; splicing regulation |
| SNRPB | Core snRNP protein | Part of U1, U2, U4/U6, U5 snRNPs; autoimmune target |
| SNRPD1 | Core snRNP protein | Component of tri-snRNP; splicing factor |
| SNRPE | Core snRNP protein | Part of U4/U6.U5 tri-snRNP |
| SNRPF | Core snRNP protein | Component of tri-snRNP; splicing |
| SNRPG | Core snRNP protein | Part of tri-snRNP; splicing |
How Is spliceosomal tri-snRNP complex assembly Regulated?
Tri-snRNP assembly is regulated by phosphorylation, particularly by PRP4 kinase, which phosphorylates PRPF6 to promote stable tri-snRNP association during B complex formation. Additionally, the nuclear cap-binding complex interacts with the tri-snRNP and enhances spliceosome assembly, linking tri-snRNP function to mRNA cap recognition. SUMOylation has also been implicated in splicing regulation, potentially affecting tri-snRNP dynamics.
spliceosomal tri-snRNP complex assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PRPF31 | Retinitis pigmentosa | Knockout or knock-in of patient mutations in retinal organoids |
| PRPF8 | Retinitis pigmentosa, cancer | CRISPR knockout in cell lines; xenograft models |
| U4 snRNA | Retinitis pigmentosa | Point mutation knock-in in iPSCs |
| U6 snRNA | Retinitis pigmentosa | Overexpression of mutant snRNA in cell lines |
| PRPF6 | Cancer, splicing dysregulation | Knockout and rescue with phospho-mimetic mutants |
Retinitis pigmentosa
Mutations in U4 and U6 snRNAs, as well as in tri-snRNP proteins such as PRPF31 and PRPF8, cause retinitis pigmentosa, a degenerative retinal disease. These mutations impair tri-snRNP assembly or stability, leading to splicing defects in photoreceptor cells.
Cancer
Dysregulation of splicing factors, including tri-snRNP components, is observed in various cancers. SUMOylation of splicing factors, which may affect tri-snRNP assembly, has been linked to cancer progression. Targeting tri-snRNP assembly could be a therapeutic strategy in cancers with splicing dependencies.
Neurodegeneration
Splicing defects contribute to neurodegenerative diseases. Although direct links between tri-snRNP assembly and neurodegeneration are less established, mutations in splicing factors cause neurological disorders, and tri-snRNP dysfunction may contribute to neuronal vulnerability.
From spliceosomal tri-snRNP complex assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does knockout of PRPF31 impair tri-snRNP assembly? | CRISPR knockout in HEK293 or retinal cells |
| How do point mutations in U4 snRNA affect splicing? | Knock-in of patient mutations in iPSCs |
| Can overexpression of PRPF6 rescue tri-snRNP defects? | Overexpression in knockout background |
| Where does PRPF8 localize in the tri-snRNP? | Tagged knock-in with fluorescent protein |
| What is the role of PRP4 kinase in tri-snRNP stability? | Point mutation of phosphorylation sites |
| How does CBC interact with tri-snRNP? | Knockout of NCBP1/2 and proteomics |
How to Study the spliceosomal tri-snRNP complex assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cryo-EM | 3D structure of tri-snRNP | Understanding assembly and conformational changes [1, 8] |
| RNA-seq | Global splicing changes | Assessing impact of tri-snRNP perturbations |
| Immunoprecipitation-MS | Protein interactions | Identifying tri-snRNP components and CBC |
| Phosphoproteomics | Phosphorylation sites | Mapping PRP4 kinase targets |
| CRISPR knockout screens | Gene essentiality | Discovering tri-snRNP assembly factors |
| Minigene splicing assay | Specific splicing efficiency | Testing tri-snRNP function |
| Fluorescence microscopy | Localization of tri-snRNP | Visualizing assembly in cells |
| In vitro assembly assays | Tri-snRNP formation | Biochemical reconstitution |
Structural biology (cryo-EM)
Cryo-electron microscopy has been used to determine the structure of the tri-snRNP and its integration into the spliceosome, revealing conformational changes and protein-RNA interactions [1, 8]. These studies provide mechanistic insights into tri-snRNP assembly and function [1, 8].
RNA-seq and splicing assays
RNA sequencing can assess global splicing changes upon perturbation of tri-snRNP components. Splicing assays with reporter minigenes can specifically measure tri-snRNP-dependent splicing events [4, 6].
Proteomics and immunoprecipitation
Affinity purification coupled with mass spectrometry can identify tri-snRNP components and their interactors, including the CBC. Phosphoproteomics can reveal regulatory phosphorylation events such as those mediated by PRP4 kinase.
CRISPR-based genetic screens
Genome-wide CRISPR knockout screens can identify genes required for tri-snRNP assembly and splicing. These screens are powerful for discovering novel regulators and disease modifiers [2, 5].
How CRISPR Can Be Used to Study GO:0000244 spliceosomal tri-snRNP complex assembly
Knockout
CRISPR knockout of tri-snRNP genes such as PRPF31 or PRPF8 can reveal their essentiality for assembly and splicing. Knockout cell lines are valuable for studying loss-of-function phenotypes and for rescue experiments [4, 5].
Point Mutation
Introducing patient-specific point mutations (e.g., in U4 snRNA or PRPF6) using CRISPR base editing or HDR can model disease-associated variants and dissect their effects on tri-snRNP assembly [5, 6].
Knock-in
Knock-in of tagged versions of tri-snRNP proteins (e.g., GFP-PRPF8) allows live-cell imaging and proteomic analysis of the complex. This approach is useful for tracking assembly dynamics [1, 7].
Overexpression
Overexpression of wild-type or mutant tri-snRNP components can test gain-of-function effects and rescue knockout phenotypes. It is also useful for producing large amounts of protein for structural studies [4, 8].
How EDITGENE Supports spliceosomal tri-snRNP complex assembly Research
Researchers studying spliceosomal tri-snRNP complex assembly-related genes often need to determine whether a candidate gene is causally involved in the assembly process, how mutations affect function, and whether the gene can be targeted therapeutically. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate these investigations.
Contact EDITGENE today to design your custom CRISPR model for spliceosomal tri-snRNP complex assembly research.
Frequently Asked Questions About spliceosomal tri-snRNP complex assembly
What is spliceosomal tri-snRNP complex assembly?
It is the process of forming the U4/U6.U5 tri-snRNP, a key building block of the spliceosome, which is essential for pre-mRNA splicing [4, 6].
What genes are involved in spliceosomal tri-snRNP complex assembly?
Key genes include PRPF4, PRPF6, PRPF8, PRPF31, PRP4 kinase, and the snRNAs U4, U6, and U5 [4, 5, 6].
What is the function of GO:0000244?
GO:0000244 describes the assembly and recycling of the tri-snRNP, ensuring efficient spliceosome formation and splicing [4, 6].
How is the tri-snRNP assembled?
It involves reannealing of U4 and U6 snRNAs, association with U5 snRNP, and regulatory phosphorylation by PRP4 kinase [4, 6].
What diseases are linked to tri-snRNP assembly defects?
Mutations in tri-snRNP components cause retinitis pigmentosa and are implicated in cancer and neurodegeneration [5, 2].
What is the role of PRP4 kinase in tri-snRNP assembly?
PRP4 kinase phosphorylates PRPF6, which is required for stable tri-snRNP association during spliceosome B complex formation.
How does the nuclear cap-binding complex affect tri-snRNP?
The CBC interacts with the tri-snRNP and promotes spliceosome assembly in mammalian cells.
What methods are used to study tri-snRNP assembly?
Cryo-EM, RNA-seq, proteomics, and CRISPR screens are commonly used [1, 4, 7].
Can CRISPR be used to study tri-snRNP assembly?
Yes, CRISPR knockout, knock-in, and point mutation models are powerful tools for dissecting tri-snRNP function [4, 5].
What is the minor tri-snRNP?
It contains U4atac/U6atac.U5 and is involved in U12-type intron splicing.
Conclusion
Spliceosomal tri-snRNP complex assembly (GO:0000244) is a fundamental process in pre-mRNA splicing, with critical roles in gene expression and human disease. Advances in structural biology, genomics, and CRISPR technologies continue to unravel the molecular details of tri-snRNP assembly and its regulation. Understanding this process offers potential therapeutic avenues for splicing-related disorders, including retinitis pigmentosa and cancer. EDITGENE's CRISPR services provide researchers with the tools needed to explore tri-snRNP biology and accelerate discoveries.
References
- 1. Zhang Z et al.. 2024. Structural insights into the cross-exon to cross-intron spliceosome switch.. Nature 630(8018):1012-1019 PMID: 38778104
- 2. Pozzi B et al.. 2018. When SUMO met splicing.. RNA Biol 15(6):689-695 PMID: 29741121
- 3. Bai R et al.. 2024. Structural basis of U12-type intron engagement by the fully assembled human minor spliceosome.. Science 383(6688):1245-1252 PMID: 38484052
- 4. Chen Z et al.. 2017. Identification of a 35S U4/U6.U5 tri-small nuclear ribonucleoprotein (tri-snRNP) complex intermediate in spliceosome assembly.. J Biol Chem 292(44):18113-18128 PMID: 28878014
- 5. Quinodoz M et al.. 2025. De novo and inherited dominant variants in U4 and U6 snRNAs cause retinitis pigmentosa.. medRxiv PMID: 39830270
- 6. Schneider M et al.. 2010. Human PRP4 kinase is required for stable tri-snRNP association during spliceosomal B complex formation.. Nat Struct Mol Biol 17(2):216-21 PMID: 20118938
- 7. Pabis M et al.. 2013. The nuclear cap-binding complex interacts with the U4/U6·U5 tri-snRNP and promotes spliceosome assembly in mammalian cells.. RNA 19(8):1054-63 PMID: 23793891
- 8. Plaschka C et al.. 2017. Structure of a pre-catalytic spliceosome.. Nature 546(7660):617-621 PMID: 28530653
